Cargando…
Serum biomarkers in interstitial lung diseases
The use of biomarkers in medicine lies in their ability to detect disease and support diagnostic and therapeutic decisions. New research and novel understanding of the molecular basis of the disease reveals an abundance of exciting new biomarkers who present a promise for use in the everyday clinica...
Autores principales: | Tzouvelekis, Argyris, Kouliatsis, George, Anevlavis, Stavros, Bouros, Demosthenes |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1215520/ https://www.ncbi.nlm.nih.gov/pubmed/16042760 http://dx.doi.org/10.1186/1465-9921-6-78 |
Ejemplares similares
-
Angiogenesis in Interstitial Lung Diseases: a pathogenetic hallmark or a bystander?
por: Tzouvelekis, Argyris, et al.
Publicado: (2006) -
Endotyping of progressive fibrotic interstitial lung diseases: It is the final destination that matters and not the journey
por: Tzouvelekis, Argyris, et al.
Publicado: (2020) -
Lung Cancer and Interstitial Lung Diseases: A Systematic Review
por: Archontogeorgis, Kostas, et al.
Publicado: (2012) -
Use of interrupter technique in assessment of bronchial responsiveness in normal subjects
por: Panagou, Panagiotis, et al.
Publicado: (2004) -
Serum biomarkers in Acute Respiratory Distress Syndrome an ailing prognosticator
por: Tzouvelekis, Argyris, et al.
Publicado: (2005)